Loading…
KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease
Level of evidence and grade of recommendations The literature collected for evidence was analyzed through systematic review, and the level of evidence was classified based on the revised Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) with modifications (Table 1). The dec...
Saved in:
Published in: | Clinical and molecular hepatology 2024, 30(0), , pp.5-105 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Level of evidence and grade of recommendations The literature collected for evidence was analyzed through systematic review, and the level of evidence was classified based on the revised Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) with modifications (Table 1). The decision to initiate treatment for CLD and its prognosis are primarily determined by the degree of liver fibrosis and its progression, as well as the risk of developing cirrhosis. [...]far, liver biopsy has been the standard test for diagnosing intrahepatic inflammation, steatosis, and fibrosis. [...]there are drawbacks such as high cost, invasiveness, risk of complications, potential for interpretation errors based on subjective judgment, and sample error due to small tissue samples [1,2]. [...]in real-world clinical practice, NITs based on imaging studies are commonly used, such as abdominal ultrasound and/or panels using serum markers. [...]the AST-to-ALT ratio (AAR) increases, allowing for |
---|---|
ISSN: | 2287-2728 2287-285X 2287-285X |
DOI: | 10.3350/cmh.2024.0506 |